Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Incyte Corporation (INCY) vs Match Group Inc (MTCH) Price & Performance

Incyte CorporationTrade
Match Group IncTrade

Price performance (Past 24H)

Key statistics

Incyte Corporation vs Match Group Inc — how do they compare? Incyte Corporation trades at $120.45 (market cap $24.54B), while Match Group Inc trades at $37 (market cap $8.45B). The key difference: Incyte Corporation is far larger — about 2.9× Match Group Inc's market cap, and Match Group Inc pays a 2.17% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.

INCYMTCH
Market Cap
$24.54B$8.45B
Sector
HealthMedia
52-Week High
$129.93$41.24
52-Week Low
$81.61$28.90
Enterprise Value
$20.04B$11.42B
Dividend Yield
2.17%

Returns comparison

Trailing returns across standard periods

About Incyte Corporation

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Read more on INCY

About Match Group Inc

Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).

Read more on MTCH